Ad-hoc | 3 August 2006 07:37

Fresenius Medical Care AG & Co. KGaA:Fresenius Medical Care Reports Second Quarter 2006 Results

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Fresenius Medical Care Reports Second Quarter 2006 Results Total revenue for the second quarter 2006 increased by 29% (30% at constant currency) to $2,165 million. The organic revenue growth worldwide was 9%. Dialysis Services revenue grew by 38% to $1,652 million (38% at constant currency). Dialysis Product revenue increased by 9% to $514 million (9% at constant currency). Operating income (EBIT) increased by 56% to $372 million. Excluding one-time effects, operating income for the second quarter 2006 increased by 42% to $340 million. Net income for the second quarter 2006 was $130 million, an increase of 12%. Excluding one-time effects, the net income increased by 19% to $139 million. Earnings per share (EPS) for the second quarter of 2006 rose by 10% to $1.32 per ordinary share. The weighted average number of shares outstanding for the second quarter of 2006 was approximately 98.0 million shares. Total revenue for the first half 2006 increased 19% (20% at constant currency) to $3,912 million. Operating income (EBIT) for the first six months increased by 34% to $616 million. Excluding one-time effects, operating income for the first half of 2006 increased by 28% to $587 million. Net income rose by 10% to $246 million in the first half of 2006. Excluding one-time effects, net income increased by 19% to $266 million. Based on the strong performance in the first half of 2006, the Company upgrades its guidance for the full year 2006. After expecting to report a revenue of about $8.1 billion, the Company now expects a revenue for 2006 of about $8.3 billion. The Company also upgrades its outlook for reported net income for 2006. After expecting a net income between $515 million and $535 million, the Company now expects to report a net income of at least $542 million, which represents an increase of at least 15% over the 2005 level. In order to show the underlying performance of the Company, the guidance does not take into effect any expected one-time items and the change of accounting principle for stock options – SFAS 123(R) in the fiscal year 2006. After previously assuming the after tax impact of one-time items and SFAS 123(R) to be about $60 million the Company now expects this impact to be about $40 million for the full year 2006. Fresenius AG (WKN 578560, 578563) holds approximately 37% of Fresenius Medical Care AG & Co. KGaA’s capital. Fresenius Medical Care AG & Co. KGaA, Represented by Fresenius Medical Care Management AG, Board of Management, Bad Homburg v.d.H., August 03, 2006 (c)DGAP 03.08.2006 ————————————————————————— Language: English Issuer: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Deutschland Phone: +49 (0) 6172- 609 2525 Fax: +49 (0) 6172- 609 2301 E-mail: ir@fmc-ag.com WWW: www.fmc-ag.de ISIN: DE0005785802, DE0005785836, WKN: 578580, 578583 Indices: DAX Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, Hannover, Stuttgart, München, Hamburg, Düsseldorf; Foreign Exchange(s) NYSE End of News DGAP News-Service —————————————————————————